Begin main content


Last Updated: January 3, 2018
Result type: Reports
Project Number: SR0556-000
Product Line: Common Drug Review

Generic Name: abobotulinumtoxinA

Brand Name: Dysport Therapeutic

Manufacturer: Ipsen Biopharmaceuticals Canada Inc.

Indications: Lower limb spasticity

Manufacturer Requested Reimbursement Criteria7: ​For the treatment of lower limb spasticity in pediatric patients 2 years of age and older.

Submission Type: New Indication

Project Status: Pending

Call For Patient Input: January 3, 2018

Patient Input Closed: February 22, 2018

Anticipated Date: January 31, 2018

Biosimilar: No

Fee Schedule1: Pending

Submit Feedback


nervous system, pediatrics